Eli Lilly’s new drug has shown significant promise in reducing the levels of Lp(a), a mysterious particle linked to increased heart attack risk. According to recent research, the treatment caused a major drop in Lp(a) blood levels. However, further study is necessary to confirm its effectiveness in preventing heart attacks and strokes. Gina Kolata, an expert on diseases and treatments, will continue to monitor this development and provide updates on its potential impact on public health.
Source: https://www.nytimes.com/2025/03/30/health/heart-attack-lpa-protein.html